WHO Director-General Race: Candidates Face Member-State Questioning in Geneva Forum

The hearings exposed sharp divides over budget cuts, drug manufacturing and who the agency serves.

The forum at WHO headquarters ran across Wednesday and continues Thursday, with the remaining three contenders — Dr Hanan Balkhy of Saudi Arabia, Spain’s Dr María Neira and Indonesia’s Budi Gunadi Sadikin — still to face delegations, Health Policy Watch reported. The winner will be chosen at the World Health Assembly’s 80th session in May 2027 and take office on 16 August 2027, according to WHO’s official announcement of candidates.

Why should anyone outside Geneva care? Because whoever wins will steer an agency that sets the medical rulebook the world actually runs on — vaccine prequalification, outbreak alerts, drug standards — at a moment when its funding has shrunk and its biggest members are openly pulling in different directions.

Rigid rules and tokens governed the forum mechanics

The mechanics were deliberately rigid. Opening statements were capped at 10 minutes, electronic presentations were barred, and two traffic-light systems enforced speaking limits across the hall, Health Policy Watch reported. Delegations dropped colour-coded tokens into six regional ballot boxes to request questions.

Executive Board Chair Tandin Wangchuk drew lots so every WHO geographic region posed an opening query. Selected nations got a single 60-second question; contenders had three minutes to reply within each 50-minute block. Between them, the four candidates answered 63 questions on Wednesday.

Those questions split along a clear geographic line. Donor governments pressed at least 14 questions on fiscal discipline, normative standards and terminating redundant programmes. African, Latin American and Asian delegations posed 19 questions on workforce retention, technology transfer and sovereign biomanufacturing.

Who geneva headquarters tmb
Photo: who.int

Four philosophies, one microphone

Former Qatari health minister Dr Hanan Mohamed Al Kuwari pitched operational discipline: refocus headquarters on core standards, delegate field delivery to external partners, and free programme directors from fundraising. “I would like the department heads, project leads, directors not to worry about the financial situation and to leave that to a team of experts,” she said.

When Iceland pressed her on sexual and reproductive health rights, she answered: “Our position will always be the science and protection of the rights of everybody regardless of race, nationality, gender, whatever, to health services.” Asked by Health Policy Watch what “gender, whatever” covers, her campaign did not respond by publication deadline.

Belgium’s nominee, WHO Europe director Dr Hans Henri P. Kluge, rejected austerity outright, arguing that promising “more with less” or “same with less” carries “no credibility.” He cited his region’s in-house AI tools — $1.3 million in staff time saved and 15,500 working hours recouped in a single year — and pledged to summon pharmaceutical chief executives to Geneva one by one.

“It cannot be that pharmaceutical interests decide on who gets medicines or not,” said Kluge.

He projected that pooled procurement and the African Medicines Agency could let the continent produce “15 to 20 vital medications” within six years. Asked by Health Policy Watch about staff complaints and formal inquiries concerning Africa CDC Director-General Jean Kaseya — whom Kluge had called “my other brother” — he did not respond.

Botswana’s nominee, Dr Gevorg Tamamyan, an Armenian paediatric oncologist, broke diplomatic decorum. He is the only contender pledging to resign after one five-year term if an independent evaluation shows he met less than 80% of his targets.

Pressed by Spain on the UNAIDS transition, he refused to bluff: “I don’t want to get into these details because I’m not an expert on this… Sorry for not being specific, but that’s my answer.”

China’s Dr Song Li, a maternal health veteran, stayed measured. She refused donor demands to name programmes facing termination, proposed mandating Global South representation on WHO expert advisory panels, and championed voluntary licensing through the Medicines Patent Pool.

Australia confronted her with the forum’s most delicate question: how an official from an emerging superpower would guard scientific independence. She deflected, defining independence as ending the dominance of traditional powers over advisory panels.

Why the next Director-General matters to markets

The candidates’ answers on regional manufacturing are not abstract. Kenya challenged Al Kuwari directly: prequalification opens factory doors, but sustained orders keep them open, Health Policy Watch reported. She agreed, tying commercial viability to public-private partnerships and concluding the Pandemic Agreement negotiations.

For investors watching pharmaceutical supply chains, the stakes are concrete. A WHO chief who pushes pooled procurement and localised production in Africa, as Kluge and Song both propose in different registers, would shift demand patterns for generic manufacturers and patent holders alike. The agency’s candidates’ forum page carries the full webcast record in six languages.

Contender Nominating state Signature pitch
Dr Hanan Mohamed Al Kuwari Qatar Operational discipline; HQ refocused on standards
Dr Hans Henri P. Kluge Belgium Rejects austerity; confronts pharma on access
Dr Song Li China Multilateral stability; Global South representation
Dr Gevorg Tamamyan Botswana Accountability; resignation pledge below 80% of targets

Small islands and middle powers challenge resource allocation

Small Island Developing States demanded an overhaul of resource allocation formulas that disqualify middle-income islands from concessional technical assistance despite climate threats and medical brain drain. Latin American delegations warned that WHO routinely bypasses their non-communicable disease burdens and high out-of-pocket costs.

Here is the underlying tension the forum made visible: a one-size-fits-all model built for the poorest states no longer fits a membership where middle-income countries carry heavy disease burdens and donor states demand cuts. Every candidate was, in effect, auditioning to reconcile that contradiction.

Candidates face questions before the 2027 appointment process

The remaining three candidates face questions on Thursday. The process then moves behind closed doors: at its 160th session in early 2027, the 34-member Executive Board will shortlist five candidates, interview them and nominate up to three for the World Health Assembly, according to WHO. A second public forum follows on March 15, 2027.

Two questions went unanswered and remain open: what Al Kuwari meant by “gender, whatever,” and whether Kluge was aware of the inquiries at Africa CDC.

The race ends in May 2027, when the Assembly appoints the new leader to succeed Tedros — and, as Song put it, remember that “All human beings… we are brothers, we are sisters, we are family.”

Photo of author

World Desk

World Desk at Archyde.

FAA Chief Takes Responsibility for Nationwide Flight Grounding, Urges Critics to ‘Lay Off’ Secretary

How the End of the Iran War Could Shift Global Capital Away From the US and AI